Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

RemeGen Co., Ltd.*

榮 昌 生 物 製 藥( 煙 台 )股 份 有 限 公 司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 9995)

CLOSURE OF REGISTER OF MEMBERS FOR 2020 ANNUAL GENERAL MEETING AND 2021 SECOND EXTRAORDINARY GENERAL MEETING

The board of RemeGen Co., Ltd.* 榮昌生物製藥(煙台)股份有限公司 (the "Company") hereby announces that, for determining the list of shareholders of H shares ("H Shares") of the Company who are entitled to attend and vote at the 2020 annual general meeting (the "AGM") and the 2021 second extraordinary general meeting (the "EGM") (to be held immediately after the conclusion of the AGM), which are scheduled to be held at 2 p.m. on Tuesday, June 1, 2021, the H Shares register of members will be closed from Sunday, May 2, 2021 to Tuesday, June 1, 2021, both days inclusive. The shareholders of H Shares whose name appear on the register of shareholders of the Company on Sunday, May 2, 2021 will be entitled to attend and vote at the AGM and the EGM. During such period, no share transfers will be registered. In order to be eligible for attending and voting at the AGM and the EGM, all transfers of H Shares accompanied by the relevant share certificates must be lodged with the Company's H share registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong not later than 4:30 p.m. on Friday, April 30, 2021. Announcement and circular containing details of the resolutions to be proposed at the AGM and the EGM, together with notice of the AGM and the EGM, will be despatched to shareholders of the Company in due course.

By Order of the Board

RemeGen Co., Ltd.*

Mr. Wang Weidong

Chairman and executive director

Yantai, The People's Republic of China

April 19, 2021

As at the date of this announcement, the Board of the Company comprises Mr. Wang Weidong, Dr. Fang Jianmin, Dr. He Ruyi and Mr. Lin Jian as the executive directors, Dr. Wang Liqiang and Dr. Su Xiaodi as the non-executive directors, and Ms. Yu Shanshan, Mr. Hao Xianjing and Dr. Lorne Alan Babiuk as the independent non-executive directors.

  • For identification purposes only

Attachments

  • Original document
  • Permalink

Disclaimer

RemeGen Co. Ltd. published this content on 19 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 01:21:00 UTC.